Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: Death; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) Regulatory authority-WEB, Regulatory authority report number FR-AFSSAPS-CN20210263. A 92-year-old male patient received the first dose of BNT162B2 (COMIRNATY, lot number: EM0477), via intramuscular at left arm on 14Jan2021 at 0.3 mL, single for COVID-19 vaccination. The patient''s medical history included severe chronic obstructive pulmonary disease (COPD), bronchial superinfection, many episodes of respiratory failure, cortico-dependence, heart failure under diuretic therapy, prostate cancer with bone metastases, major neurocognitive disorders of vascular origin, repeated falls and anticoagulant therapy. The patient had no history of COVID-19. Patient had PCR test history with unknown results. COVID-19 risk factors included heart and respiratory failure. Allergic history was unknown. Concomitant medications were not reported. Death was observed on 16Jan2021, without signs of poor tolerance since vaccination. Patient was found dead in bed in the morning. The patient died on 16Jan2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166